Literature DB >> 15245461

Evolution of redo cardiac surgery: review of personal experience.

Lawrence H Cohn1.   

Abstract

This presentation summarizes the author's personal observations on the major advances in reoperative cardiac surgery. They include earlier referral for cardiac prosthetic and bioprosthetic cardiac valve dysfunction, alternative incisional approaches to minimize injury to adherent cardiac structures, alternative perfusion sites, improved hemostasis on cardiopulmonary bypass, improved myocardial protection, tailoring the valve prosthesis to the patients' anatomy and clinical situation, "no-touch" technique in reoperative coronary artery surgery, and increasing use of hypothermic circulatory arrest for recurrent ascending arch and descending thoracic pathology. Each of these is explained in detail with the appropriate references and retrospective data collections where appropriate. This risk of reoperative cardiac surgery will continue to improve as these and additional techniques continue to evolve and become simplified. Further investigation into the clinical uses of minimally invasive techniques including robot technology, may eventually reduce morbidity and mortality of reoperations to that equal to primary operations.

Entities:  

Mesh:

Year:  2004        PMID: 15245461     DOI: 10.1111/j.0886-0440.2004.4057_11.x

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  8 in total

1.  A right thoracotomy approach for mitral and tricuspid valve surgery in patients with previous standard sternotomy: comparison with a re-sternotomy approach.

Authors:  Takashi Miura; Kazuyoshi Tanigawa; Seiji Matsukuma; Ichiro Matsumaru; Kazuki Hisatomi; Shiro Hazama; Akira Tsuneto; Kiyoyuki Eishi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-03-11

Review 2.  Minimally invasive approach for redo mitral valve surgery.

Authors:  Luca Botta; Aldo Cannata; Giuseppe Bruschi; Pasquale Fratto; Corrado Taglieri; Claudio Francesco Russo; Luigi Martinelli
Journal:  J Thorac Dis       Date:  2013-11       Impact factor: 2.895

3.  Right mini-thoracotomy approach in patients undergoing redo mitral valve procedure.

Authors:  Nadejda Monsefi; Mahmut Öztürk; Tunjay Shavahatli; Farhad Bakhtiary
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-08-20

4.  The Use of Hypothermic Circulatory Arrest During Heart Transplantation Does Not Worsen Posttransplant Survival.

Authors:  Robert A Sorabella; Laura Guglielmetti; Amanda Bader; Andres Gomez; Koji Takeda; Paul J Chai; Hiroo Takayama; Emile A Bacha; Yoshifumi Naka; Isaac George
Journal:  Ann Thorac Surg       Date:  2016-05-19       Impact factor: 4.330

5.  Transapical transcatheter aortic valve replacement in patients with or without prior coronary artery bypass graft operation.

Authors:  Konstantinos V Voudris; S Chiu Wong; Ryan Kaple; Polydoros N Kampaktsis; Andreas R de Biasi; Jonathan S Weiss; Richard Devereux; Karl Krieger; Luke Kim; Rajesh V Swaminathan; Dmitriy N Feldman; Harsimran Singh; Nikolaos J Skubas; Robert M Minutello; Geoffrey Bergman; Arash Salemi
Journal:  J Cardiothorac Surg       Date:  2016-11-29       Impact factor: 1.637

6.  Right minithoracotomy and resternotomy approach in patients undergoing a redo mitral valve procedure.

Authors:  Nadejda Monsefi; Basel Makkawi; Mahmut Öztürk; Hossien Alirezai; Eissa Alaj; Farhad Bakhtiary
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-08-15

7.  Mini-thoracotomy in redo mitral valve surgery: safety and efficacy of a standardized procedure.

Authors:  Filippo Prestipino; Riccardo D'Ascoli; Ádám Nagy; Gianluca Paternoster; Erica Manzan; Giampaolo Luzi
Journal:  J Thorac Dis       Date:  2021-09       Impact factor: 2.895

8.  Long-term outcomes of a totally thoracoscopic approach for reoperative mitral valve replacement: a propensity score matched analysis.

Authors:  Peijian Wei; Jian Liu; Jiexu Ma; Yuyuan Zhang; Zhao Chen; Yanjun Liu; Tong Tan; Hongxiang Wu; Jimei Chen; Jian Zhuang; Huiming Guo
Journal:  Ann Transl Med       Date:  2021-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.